Expectations for Artificial Intelligence (AI) in Psychiatry
- PMID: 36214931
- PMCID: PMC9549456
- DOI: 10.1007/s11920-022-01378-5
Expectations for Artificial Intelligence (AI) in Psychiatry
Abstract
Purpose of review: Artificial intelligence (AI) is often presented as a transformative technology for clinical medicine even though the current technology maturity of AI is low. The purpose of this narrative review is to describe the complex reasons for the low technology maturity and set realistic expectations for the safe, routine use of AI in clinical medicine.
Recent findings: For AI to be productive in clinical medicine, many diverse factors that contribute to the low maturity level need to be addressed. These include technical problems such as data quality, dataset shift, black-box opacity, validation and regulatory challenges, and human factors such as a lack of education in AI, workflow changes, automation bias, and deskilling. There will also be new and unanticipated safety risks with the introduction of AI. The solutions to these issues are complex and will take time to discover, develop, validate, and implement. However, addressing the many problems in a methodical manner will expedite the safe and beneficial use of AI to augment medical decision making in psychiatry.
Keywords: Artificial intelligence; Machine learning; Psychiatry; Technology maturity.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
EA has served on advisory boards or consulted for Alkermes, Atheneum, Janssen, Karuna, Lundbeck/Otsuka, Roche, Sunovion, and Teva and reports previous stock holdings in AstraZeneca, Johnson & Johnson, Moderna, and Pfizer. EA has received research support from Alkermes, Astellas, Biogen, Boehringer-Ingelheim, InnateVR, Janssen, National Network of Depression Centers, Neurocrine Biosciences, Novartis, Otsuka, Pear Therapeutics, and Takeda. EA serves as an advisor to CAPNOS Zero, the World Psychiatric Association and Clubhouse International, and the SMI Adviser LAI Center of Excellence (all unpaid). The other authors declare no competing interests.
References
-
- Solow RM. “We’d better watch out” review of manufacturing matters: the myth of the post-industrial economy, by Stephen S. Cohen and John Zysman, New York Times, 1987.
-
- Brynjolfsson E, Hitt LM. Beyond the productivity paradox. Commun ACM. 1998;41:49–55. https://dl.acm.org/doi/pdf/10.1145/280324.280332. Accessed 4 Sept 2022. - DOI
-
- Bronsoler A, Doyle JJ Jr, Van Reenen J. The impact of healthcare IT on clinical quality, productivity and workers. Natl Bureau Econ Res. 2021. https://www.nber.org/papers/w29218. Accessed 4 Sept 2022.
-
- Bui QN, Hansen S, Liu M, Tu Q. The productivity paradox in health information technology. Commun ACM. 2018;61:78–85. doi: 10.1145/3183583. - DOI
-
- Schweikl S, Obermaier R. Lessons from three decades of IT productivity research: towards a better understanding of IT-induced productivity effects. Management Review Quarterly. 2020;70:461–507. doi: 10.1007/s11301-019-00173-6. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials